Molecular structures provide roadmap for targeted Parkinson's disease therapeutics
August 10, 2026
August 10, 2026
ITHACA, New York, Aug. 10 -- Cornell University posted the following news:
* * *
Molecular structures provide roadmap for targeted Parkinson's disease therapeutics
*
Researchers at Weill Cornell Medicine have uncovered how a key Parkinson's protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.
Mutations th . . .
* * *
Molecular structures provide roadmap for targeted Parkinson's disease therapeutics
*
Researchers at Weill Cornell Medicine have uncovered how a key Parkinson's protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.
Mutations th . . .